Biochem/physiol Actions
Sumatriptan succinate is a 5-HT1 serotonin receptor agonist.
Sumatriptan succinate has the ability to constrict human cranial arteries. This 5-HT1 receptor agonist can be used to treat migraine.
Features and Benefits
This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Packaging
10, 50 mg in glass bottle
This product has met the following criteria to qualify for the following awards: